← All Evommune, INC filings

Evommune, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NYSE
EVMN
Evommune, INC
SCHEDULE: LSP 7 Boosts Evommune Stake to 14.7% in $10M Private Placement
LSP 7 Cooperatieve U.A. increased its beneficial ownership in Evommune, Inc. to 14.7% by purchasing 358,680 shares for nearly $10 million in a recent private placement.